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           A persistent increase in endothelial permeability 
during infl  ammatory conditions such as pneu-
monia, trauma, and burn leads to the life-threat-
ening illness acute respiratory distress syndrome 
(  Mehta and Malik, 2006  ;   Liu and Matthay, 
2008  ). Increased endothelial permeability 
occurs because of loss of cell–cell contacts and 
disruption of cell–extracellular matrix (ECM) 
adhesions ( Yuan, 2002 ;  Mehta and Malik, 2006 ). 
Focal adhesion kinase (FAK) and VE-cadherin 
play a fundamental role in establishing the en-
dothelial barrier to macromolecules and liquid 
by maintaining intercellular adhesion and cell–
ECM adhesivity (  Nelson et al., 2004  ;   van Buul 
et al., 2005  ;   Wu, 2005  ;   Mehta and Malik, 2006  ; 
  Dejana et al., 2008  ;   Rudini and Dejana, 2008  ). 
We have shown that thrombin, a serine prote-
ase generated early on during acute respiratory 
distress syndrome, plays a critical role in increas-
ing endothelial permeability by inducing the 
loss of VE-cadherin homotypic adhesion and 
redistribution of focal adhesions dependent on 
FAK (  Mehta et al., 2002  ;   Kouklis et al., 2004  ; 
  Holinstat et al., 2006  ). Interestingly, the throm-
bin-induced increase in endothelial permeabil-
ity is reversed within 2–3 h, indicating activation 
of endogenous pathways that limit the persistent 
increase in endothelial permeability produced 
by thrombin (  Kouklis et al., 2004  ;   Holinstat 
et al., 2006  ;   Kaneider et al., 2007  ). 
  Thrombin binds to endothelial cell surface 
receptor, protease-activating receptor 1 (PAR1) 
and PAR4 (  Coughlin, 2000  ,   2005  ;   Kataoka 
et al., 2003  ). We have shown that the permea-
bility increasing eff  ects of thrombin in lung en-
dothelium are predominantly mediated through 
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  The infl  ammatory mediator thrombin proteolytically activates protease-activated receptor 
(PAR1) eliciting a transient, but reversible increase in vascular permeability. PAR1-induced 
dissociation of G     subunit from heterotrimeric Gq and G12/G13 proteins is known to signal 
the increase in endothelial permeability. However, the role of released G         is unknown. We 
now show that impairment of G         function does not affect the permeability increase 
induced by PAR1, but prevents reannealing of adherens junctions (AJ), thereby persistently 
elevating endothelial permeability. We observed that in the naive endothelium G    1, the 
predominant G     isoform is sequestered by receptor for activated C kinase 1 (RACK1). 
Thrombin induced dissociation of G    1 from RACK1, resulting in G    1 interaction with Fyn 
and focal adhesion kinase (FAK) required for FAK activation. RACK1 depletion triggered 
G    1 activation of FAK and endothelial barrier recovery, whereas Fyn knockdown inter-
rupted with G    1-induced barrier recovery indicating RACK1 negatively regulates G    1-Fyn 
signaling. Activated FAK associated with AJ and stimulated AJ reassembly in a Fyn-dependent 
manner. Fyn deletion prevented FAK activation and augmented lung vascular permeability 
increase induced by PAR1 agonist. Rescuing FAK activation in   fyn      /        mice attenuated the 
rise in lung vascular permeability. Our results demonstrate that G    1-mediated Fyn activa-
tion integrates FAK with AJ, preventing persistent endothelial 
barrier leakiness. 
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    Figure 1.     Inhibition of G         prevents reannealing of AJ and restoration of endothelial barrier permeability after thrombin stimulation.  
(A) Effect of G         inhibition on adherens junction reassembly. (top) HPAE cells were infected with adenovirus (Ad) containing either control vector or 
CT-     ARK1 for 6 h in serum-free medium, after which the medium was replaced with fresh complete medium without virus. After 34 h, cells were stimu-
lated with 50 nM thrombin for indicated times, fi  xed, permeabilized, and stained with anti–VE cadherin Ab followed by incubation with Alexa Fluor–
labeled secondary Ab as described in Materials and methods. (inset) The expression of CT-     ARK in HPAE cell lysates was determined by immunoblotting 
with anti-GRK2 Ab. (bottom) Plot shows mean ± SD of interendothelial gaps formed in monolayers transduced with CT-     ARK1 after thrombin stimula-
tion at indicated times from three independent experiments. * indicates signifi  cant increase in gap area from that in unstimulated (zero time) monolayers 
transduced with control vector (Ad-control; P < 0.05);   #   indicates  signifi  cant increase in gap area in monolayers transduced with CT-    ARK1  compared 
with monolayers transduced with control vector after thrombin stimulation (P < 0.05). (B) Effect of G         inhibition on endothelial permeability. HPAE 
monolayers infected with Ad-control vector or Ad-CT-     ARK1 were stimulated with 50 nM thrombin, and changes in TER, a dynamic assessment of inter-
cellular adhesion, were determined over time. Data represent mean ± SD from four experiments performed in duplicates. * indicates signifi  cance from Ad-
control monolayer (P < 0.05). (C) Effect of G     1 knockdown on adherens junction assembly.     (top left) G      expression in HPAE cells. RNA isolated from HPAE 
cells were reverse transcribed using various G      primers as described in Materials and methods. GAPDH primers were used as a positive control (+), 
whereas RNA without primers (     ) was used as a negative control. Results are representative of fi  ndings from at least three similar experiments. (top JEM VOL. 206, November 23, 2009 
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right) HPAE cells transfected with either scrambled siRNA (SiSc) or G    1siRNA  (SiG    1) were immunoblotted with anti-G     1 (top) or anti-FAK (bottom) Abs 
to determine knock down of G     1. Mean ± SD densitometric values of G     1 expression normalized against FAK expression. Data represent experiments 
that were repeated three times. * indicates signifi  cance (P < 0.05). (bottom) Graph quantifi  es mean ± SD of interendothelial gaps formed in monolayers 
transfected with SiSc or SiG     1 without or with thrombin stimulation from three independent experiments. * indicates signifi  cance from unstimulated 
SiSc-transfected monolayers (P < 0.05);   #   indicates  signifi  cance from thrombin-stimulated SiSc transfected monolayers (P < 0.05). (D) Effect of G    1 
knockdown on endothelial permeability. HPAE cells transduced with SiSc or SiG     1 were stimulated with 50 nM thrombin and TER across the endothelial 
monolayer was recorded. Data represent mean ± SD from four experiments performed in duplicates (  n   = 4). * indicates signifi  cance from SiSc-transfected 
endothelial monolayers (P < 0.05).     
 
PAR1 because thrombin and selective PAR1 peptide ago-
nists failed to induce endothelial contraction and lung micro-
vascular permeability increase in mice lacking PAR1 (  Vogel 
et al. 2000  ). PAR1 is a seven-transmembrane domain recep-
tor that couples to heterotrimeric G proteins of the Gq and 
G12/13 families (  Hung et al., 1992  ;   Coughlin 1999  ). Upon 
ligation by thrombin, PAR1 signals the dissociation of the      -
subunits of Gq and G12/13 from the G           dimer. G     q and 
G     12/13 activate myosin light chain kinase and RhoA path-
ways, which by inducing endothelial cell contraction increase 
permeability (  Goeckeler and Wysolmerski, 1995  ;   Dudek and 
Garcia, 2001  ;   Holinstat et al., 2003  ;   McLaughlin et al., 2005  ; 
  Knezevic et al., 2007  ;   Singh et al., 2007  ;   Gavard and Gutkind, 
2008  ;   Korhonen et al., 2009  ). However, the role of G           af-
ter its dissociation from these heterotrimeric G proteins in 
the mechanism of PAR1-induced alteration in endothelial 
barrier function is unknown. 
  The G           pathway has progressively emerged as a critical 
element of GPCR signaling (  Clapham and Neer, 1997  ;   
Cabrera-Vera et al., 2003  ;   Oldham and Hamm, 2008  ). G           
is known to induce cyclic AMP generation (  Tang and Gilman, 
1992  ;   Taurin et al., 2007  ), Ca  2+   signaling (  Herlitze et al., 
1996  ;   Blackmer et al., 2001  ), oxidant generation (  Niu et al., 
2003  ), neurotransmission (  Blackmer et al., 2005  ), chemotaxis 
(  Neptune and Bourne, 1997  ;   Jin et al., 2000  ), and caveolae-
mediated transcytosis (  Shajahan et al., 2004  ). The       subunit of 
G           contains WD 40 repeats that are thought to mediate 
protein–protein interactions (  Neer et al., 1994  ;   Chen et al., 
2004b  ). Studies show that G      interacts with receptor for acti-
vated C kinase 1 (RACK1;   Dell et al., 2002  ;   Chen et al., 
2004a  ), p60cSrc (  Luttrell et al., 1996  ;   McGarrigle and Huang, 
2007  ), and Fyn (  Yaka et al., 2002  ;   Thornton et al., 2004  ). 
Fyn, p60cSrc, and RACK1 are known to infl  uence adherens 
junctions (AJ) and focal adhesions (  Xing et al., 1994  ;   Bockholt 
and Burridge, 1995  ;   Thomas and Brugge, 1997  ;   Roura et al., 
1999  ;   Owens et al., 2000  ;   Mourton et al., 2001  ;   Schaller, 
2001  ;   Piedra et al., 2003  ). We tested the hypothesis that, be-
sides restraining G      subunits, G           orchestrates signaling to 
terminate endothelial permeability increase through its ability 
to coordinate intercellular and cell–matrix interactions. 
  To explore the function of G           in regulating endothelial 
permeability, we interfered with expression of G         , RACK1, 
or Fyn using small interfering RNA (siRNA) or Fyn knock-
out mice. We show that G           plays a fundamental role in sig-
naling endothelial barrier recovery. Moreover, we identifi  ed 
Fyn and FAK as the key downstream effectors of G          . 
Fyn-mediated activation of FAK facilitated the association of 
FAK with p120-catenin and reannealing of AJ, which re-
versed the increased endothelial permeability responses pro-
duced by G protein–coupled receptor agonists. 
  RESULTS 
  G         is required for reannealing AJ and for restoration 
of endothelial barrier function 
  To address the contribution of G           to the mechanism of in-
creased endothelial permeability, we transduced the 194-aa 
C terminus of      -adrenergic receptor kinase 1 (CT-     ARK-1; 
  Drazner et al. 1997  ) in endothelial cells to inhibit G           (  Fig. 1 A  , 
inset).   Changes in endothelial permeability were determined by 
quantifying interendothelial gap area in endothelial monolayers 
immunostained with anti–VE-cadherin antibody (Ab) and dy-
namically by determining the decrease in transendothelial elec-
trical resistance (TER) after thrombin challenge. Consistent with 
our previous study (  Holinstat et al., 2006  ), thrombin rapidly dis-
rupted AJ, induced gap formation (  Fig. 1 A  ), and decreased 
TER (  Fig. 1 B  ) in cells receiving control vector. AJ subsequently 
reannealed, as interendothelial gaps closed and TER returned to 
basal levels within 2 h (  Fig. 1, A and B  ). Inhibition of G           did 
not aff  ect the acute disruption of AJ, interendothelial gap forma-
tion, or TER decrease induced by thrombin, but in contrast to 
control cells, these thrombin responses persisted without recov-
ery to basal level (  Fig. 1, A and B  ). 
  The       subunit must dimerize with the       subunit in order for 
G           to function normally (  Jones et al., 2004  ). Approximately 
12       isoforms and 5       isoforms are reported in various cell types 
(  Hurowitz et al., 2000  ;   Robishaw and Berlot, 2004  ). Our semi-
quantitative RT-PCR analysis of human pulmonary arterial 
endothelial (HPAE) cells demonstrated that two       isoforms are 
expressed in endothelial cells, of which the      1 is the predomi-
nant isoform (  Fig. 1 C  , top left). Therefore, we targeted the      1 
isoform to achieve the maximal disruption of the G           dimer. 
Using siRNA, we depleted G     1 (  Fig. 1 C  , top right) and deter-
mined the eff  ect of G     1 depletion on the endothelial barrier re-
covery response. We observed that in G     1 knockdown cells, 
thrombin induced an irreversible disruption of AJ (  Fig. 1 C  ) re-
sulting in a persistent increase in the duration of endothelial per-
meability responses (  Fig. 1 D  ), confi  rming our fi  ndings that 
G           is required to restore basal endothelial barrier function. 
  G         mediates FAK activation 
  Based on our previous study showing that FAK, upon being 
phosphorylated at tyrosine residues Y397 and Y576, suppresses 2764 G         reverses increased endothelial permeability   | Knezevic et al. 
tion. Endothelial cells transfected with CT-     ARK-1 or G     1 
siRNA were stimulated with thrombin for the indicated 
times and FAK activation was determined by using anti-Y397 
RhoA activation and thereby promotes restoration of basal 
endothelial barrier function (  Holinstat et al., 2006  ), we ad-
dressed the possible role of G           in regulating FAK activa-
    Figure 2.     G         is required to induce FAK activity.   (A and B) Effect of G         inhibition on FAK activity. HPAE cells infected with Ad-CT-     ARK1 (A) or 
transfected with SiG     1 (B) were stimulated with 50 nM thrombin for indicated times. Lysates were immunoblotted with Y397 or Y576 residue specifi  c 
anti–phospho-Abs or pan anti–FAK Abs to determine phosphorylation of FAK. Immunoblot with anti-GRK2 Ab was performed to confi  rm the expression 
of CT-     ARK1. Data representative of at least three experiments. * indicates signifi  cant increase in phosphorylation (P < 0.05). (C) Effect of G         inhibition 
on RhoA-GTPase activity. HPAE cells infected with indicated adenovirus were stimulated with 50 nM thrombin for 0, 2, or 10 min to determine RhoA 
activity. RhoA activity was measured by the increased amount of RhoA bound to GST-bound rhotekin fusion proteins, GTP-bound RhoA (top), compared 
with the total amount of RhoA in whole cell lysate (bottom). Data represent mean ± SD from three individual experiments. * indicates signifi  cance from 
Ad-control transducing unstimulated monolayer (P < 0.05);   #   indicates  signifi  cance from thrombin stimulated Ad-control monolayers (P < 0.05). (D) G        
activation with mSIRK induces FAK phosphorylation. HPAE cells were stimulated with 10 μM mSIRK for indicated times. The peptide L9A-mSIRK (where 
substitution of residue Leu 9 for Ala decreases the binding affi  nity of this peptide to G         by >100-fold) was used as a control. Cell lysates were immuno-
blotted with anti-phospho-Y397 or -Y576 residue–specifi  c antibodies or pan anti-FAK Abs to determine FAK phosphorylation. Data represent mean ± 
SD from three individual experiments. * indicates signifi  cant increase in phosphorylation above time zero (P < 0.05). (E) Effect of G         activation on adhe-
rens junction assembly. HPAE cells were preincubated with 10 μM mSIRK or mSIRK-L9A (control peptide) 15 min before stimulation with 50 nM thrombin, 
and after indicated times cells were fi  xed, permeabilized, and stained with anti–VE cadherin Ab. Plot shows mean ± SD of interendothelial gap formation 
after thrombin stimulation. Results were quantifi  ed from three independent experiments. * indicates signifi  cant increase in gap area in monolayers ex-
posed to control peptide (P < 0.05). (F) Effect of G         activation on endothelial permeability. HPAE cells were preincubated with 10 μM mSIRK or mSIRK-
L9A 15 min before stimulation with 50 nM thrombin and TER across the endothelial monolayer was recorded. Data represent mean ± SD from four 
experiments performed in duplicate. * indicates signifi  cance decrease in TER in mSIRK-pretreated endothelial monolayers (P < 0.05).     JEM VOL. 206, November 23, 2009 
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tion of endothelial barrier function in RACK1-defi  cient 
endothelial cells (  Fig. 4 D  ). 
  G    1 interaction with Fyn is required 
for FAK phosphorylation 
  We addressed the possibility that a physical interaction be-
tween G     1 and Fyn contributes to Fyn activation of FAK. 
We fi  rst determined whether thrombin phosphorylates Fyn 
in a G     1-dependent manner. HPAE cells transfected with G     1 
siRNA or scrambled siRNA were stimulated with thrombin 
and lysed. Lysates were immunoprecipitated with anti-Fyn 
Ab, and tyrosine phosphorylation was assessed using phos-
photyrosine Abs. Under control conditions (scrambled 
siRNA-transfected cells), we observed that thrombin chal-
lenge increased tyrosine phosphorylation of Fyn above basal 
(  Fig. 5 A  ).   However, basal Fyn phosphorylation was reduced 
to undetectable levels in G     1-depleted cells and did not in-
crease after thrombin stimulation (  Fig. 5 A  ). 
or anti-Y576 phospho-FAK antibodies. We found that G     1      
was necessary for FAK activation because thrombin failed to 
increase FAK phosphorylation at 397 and 576 Tyr residues in 
endothelial cells expressing CT-     ARK-1 (  Fig. 2 A  ) or trans-
fected with G     1 siRNA (  Fig. 2 B  ).   Inhibition of G           in-
creased basal RhoA activity and potentiated the increase in 
RhoA activation in response to thrombin (  Fig. 2 C  ), in agree-
ment with our previous study (  Holinstat et al. 2006  ). 
  We next used the cell-permeant G          -activating peptide 
mSIRK (  Goubaeva et al. 2003  ) to further substantiate the role 
of G           in regulating FAK activation. Stimulation of HPAE 
cells with mSIRK induced FAK phosphorylation at both 
sites without thrombin stimulation; control peptide, i.e., L9A 
mSIRK, was ineff  ective (  Fig. 2 D  ). mSIRK also counteracted 
the disruptive eff  ect of thrombin on AJ (  Fig. 2 E  ), and thereby 
markedly suppressed thrombin-induced increase in endothelial 
permeability (  Fig. 2 F  ). These fi  ndings support the conclusion 
that up-regulation of FAK activity by G           induces barrier re-
pair by facilitating reannealing of AJ, which thus prevents per-
sistent increase in endothelial permeability. 
  Thrombin induces the formation 
of G    1    2–Fyn–FAK complex 
  G     1 belongs to a large family of WD 40 proteins and shares 
57% amino acid homology with its binding partner RACK1 
(  Chen et al., 2004b  ). RACK1 also binds Fyn, a Src family 
nonreceptor tyrosine kinase that phosphorylates FAK (  Yaka 
et al., 2002  ). To address the mechanism of G     1 up-regulation 
of FAK activity, we determined whether thrombin induces 
formation of a signaling complex consisting of G     1, RACK1, 
and Fyn. To do this, we cotransduced endothelial cells with 
GFP-tagged G     1 and GFP-tagged G     2 and used coimmuno-
precipitation assay to detect complex formation. We noted 
that in unstimulated endothelial cells, G     1     2-associated with 
RACK1 and Fyn (  Fig. 3  ).   However, under these conditions, 
an association between G     1     2 and FAK was not found. 
Thrombin potentiated the interaction of G     1     2 with Fyn and 
FAK within 10–30 min, but induced a transient dissociation of 
RACK1 from G     1     2 (  Fig. 3  ) that correlated with FAK acti-
vation, initiation of AJ reannealing, and recovery of endothe-
lial barrier function, as shown in   Figs. 1   and   2  . 
  RACK1 negatively regulates G    1–Fyn interaction, FAK 
activation, AJ resealing, and restoration of endothelial 
barrier function 
  Next, we suppressed endogenous expression of RACK1 
to assess the causal role of RACK1 in regulating G     1–Fyn 
interaction, FAK activation, and endothelial barrier per-
meability. We observed that knockdown of RACK1-
potentiated basal interaction of G     1 with Fyn and FAK, 
which did not increase further after thrombin stimulation 
(  Fig. 4 A  ).   Suppression of endogenous RACK1 basally ac-
tivated FAK (  Fig. 4 B  ), and signifi  cantly accelerated rean-
nealing of AJ within 10 min (  Fig. 4 C  ), thereby speeding 
recovery of endothelial barrier function (  Fig. 4 D  ). We 
noted a marked suppression of thrombin-induced disrup-
    Figure 3.     RACK1 dissociation from G    1    2 leads to ternary com-
plex formation between G    1    2, Fyn, and FAK.   HPAE cells cotrans-
duced with GFP-tagged G     1 and GFP-tagged      2 were stimulated with 
50 nM thrombin for indicated times and lysates were immunoprecipitated 
with anti-GFP Ab. Immunocomplexes were immunoblotted with anti-
RACK1, anti-Fyn, and anti-FAK Abs to determine complex formation. 
Immunoblot with anti-GFP Ab was performed to confi  rm GFP expression 
to indicate equal protein loading. (top) A representative immunoblot. 
(bottom) The plot of densitometry analysis of interaction. Data represent 
mean ± SD from four experiments. * indicates signifi  cance (P < 0.05).     2766 G         reverses increased endothelial permeability   | Knezevic et al. 
  Fyn is required for G    1-mediated FAK activation 
and endothelial barrier restoration 
  We suppressed endogenous expression of Fyn in endothelial 
cells to assess the specifi  c role of Fyn in mediating G     1-
induced FAK activation and endothelial barrier repair. Western 
blot analysis showed that suppression of Fyn expression did 
not alter the expression of Src family kinase p60cSrc (  Fig. 6 A  , 
inset).   Depletion of Fyn did not alter the basal or thrombin-
induced association of G     1 with RACK1. However, G     1 
failed to interact with FAK in Fyn-depleted cells (  Fig. 6 A  ), 
and under these conditions FAK phosphorylation on 397 or 
576 tyrosine residues was not found (  Fig. 6 B  ). Fyn knock-
down did not alter transfer of Evans blue–conjugated albu-
min across the endothelial monolayer (0.11 ± 0.01 vs. 0.10 ± 
  To determine the eff  ect of G     1 knockdown on the ac-
tivity of Fyn kinase (which phosphorylates FAK), we per-
formed an in vitro kinase assay using recombinant FAK as a 
substrate. Fyn immunocomplexes obtained from cells trans-
fected with G     1 siRNA were incubated with recombinant 
FAK and tyrosine phosphorylation of recombinant FAK was 
determined using phosphotyrosine Abs. In parallel, Fyn ki-
nase activity was determined in cells transfected with RACK1 
siRNA. We observed that Fyn immunoprecipitated from 
endothelial cells transfected with control siRNA or RACK1 
siRNA phosphorylated recombinant FAK (  Fig. 5 B  ). How-
ever, Fyn immunoprecipitated from G     1-siRNA–trans-
fected cells failed to phosphorylate FAK, demonstrating that 
G     1 is required to induce Fyn activation (  Fig. 5 B  ). 
    Figure 4.     Effect of knockdown of RACK1 on G    1 function.   (A) Knockdown of RACK1 increases G     1 interaction with Fyn and FAK. HPAE cells 
transduced with either SiSc or SiRACK1 were stimulated with 50 nM thrombin for indicated times. Lysates were immunoprecipitated with anti-Fyn Ab 
and immunoblotted with anti-G     1 or anti-FAK Abs to assess interaction. Immunoblot with anti-RACK1 Ab was performed to determine RACK1 knock-
down while immunoblot with anti-Fyn Abs was performed to assess equal protein loading. Data represent results from three individual experiments. 
(B) Knock down of RACK1 increases basal FAK phosphorylation. Lysates from cells transduced by SiSc or SiRACK1 were immunoblotted with anti–phospho-
Y397, anti–phospho-Y576, or anti-FAK Abs to determine changes in FAK phosphorylation. Data representative of three independent experiments. * indi-
cates signifi  cant difference in densitometric values of phospho FAK over unstimulated SiSc-transfected cells at time zero (P < 0.05). (C) Effect of RACK1 
knockdown on adherens junction reassembly. After 48 h, HPAE monolayers transfected with SiSc or SiRACK1 were stimulated with 50 nM thrombin for 
indicated times and stained with anti-VE cadherin and anti-RACK1 Abs, followed by incubation with appropriate Alexa Fluor–labeled secondary Ab. Plot 
quantifi  es mean ± SD of interendothelial gaps formed in monolayers from three experiments. * indicates signifi  cance from unstimulated monolayer (P < 
0.05);   #   indicates signifi  cance from SiSc-transfected cells (P < 0.05). (D) Knockdown of RACK1 promotes endothelial barrier restoration after thrombin-
induced increase in endothelial permeability. HPAE cells transduced with SiSc or SiRACK1 were stimulated with 50 nM of thrombin and changes in TER 
were recorded to assess the role of RACK1 knockdown on endothelial permeability. Data represent mean ± SD from at least three experiments performed 
in duplicates. * indicates signifi  cance (P < 0.05).     JEM VOL. 206, November 23, 2009 
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ratio after PAR1 activation. Lung vascular albumin permeabil-
ity was the same in WT and   fyn       /         mice receiving a scrambled 
PAR1 peptide (  Fig. 7, D and E  ). However, injection of PAR1 
peptide (i.v.) produced a signifi  cantly greater increase in EBAE 
(  Fig. 7 D  ) and edema formation (  Fig. 7 E  ) in the Fyn knock-
out, indicating that Fyn mitigates PAR1-agonist–induced pul-
monary edema. 
  Fyn is required for FAK-mediated recovery of AJ 
  To assess whether Fyn-dependent activation of FAK induces 
the association of FAK with endothelial junctions, we obtained 
lysates from WT and   fyn       /         mice stimulated with PAR1-
activating peptide, immunoprecipitated FAK with anti-FAK 
Ab, and immunoblotted with anti–p120-catenin Ab. PAR1 
activation markedly increased the association between FAK 
and p120-catenin (a marker of endothelial junctions) between 
15 and 30 min in WT but not   fyn       /         lungs (  Fig. 8 A  ).   Fyn dele-
tion had no eff  ect on p120-catenin expression (  Fig. 8 A  ). The 
results indicate that Fyn-dependent phosphorylation of FAK 
induces association between FAK and AJ. 
  To demonstrate that FAK and AJ associate in endothelial 
cells, we coimmunostained HPAE cells with anti-FAK and 
anti–p120-catenin antibodies. As expected, FAK localized at 
focal adhesions under basal conditions and to a greater extent 
after thrombin challenge (  Fig. 8 B  ). FAK also colocalized 
with p120-catenin under basal conditions, and the association 
was signifi  cantly increased by thrombin (  Fig. 8 B  ). No inter-
action was found between FAK and isotype-matched control 
IgG Ab (unpublished data). 
  FAK-397/-576 phosphorylation mimicking mutant rescues 
lung vascular permeability in   fyn      /        mice 
  Because Fyn deletion prevented FAK phosphorylation at tyro-
sine residues 397 and 576 (  Fig. 7 A  ), we generated a phosphory-
lation-mimicking mutant of FAK to test whether restoring FAK 
phosphorylation in the   fyn         /       mouse lung could restore lung 
0.01 μl/min) or basal TER (  Fig. 6 C  ). However, suppression 
of endogenous Fyn expression resulted in irreversible increase 
in endothelial permeability after thrombin challenge (  Fig. 6 C  ). 
In contrast, knockdown of p60cSrc signifi  cantly inhibited 
thrombin-induced increase in endothelial permeability 
(  Fig. 6 C  ). These fi  ndings demonstrate that downstream of 
G     1, Fyn plays a key role in mediating FAK activation and 
endothelial barrier repair. Our data also suggest that Fyn and 
p60cSrc play contrasting roles in PAR1 regulation of endo-
thelial permeability. 
  Genetic deletion of Fyn leads to increased lung 
microvascular permeability 
  In another series of experiments, we investigated the role of 
Fyn in regulating endothelial barrier integrity of pulmonary 
microvessels using Fyn-defi  cient mice. First we determined 
whether activation of PAR1 by the specifi  c activating peptide 
TFLLRN alters FAK activity in lungs. WT or   fyn       /         mice 
received i.v. injection of either control peptide or PAR1-
activating peptide (1 mg/kg). Lungs were homogenized to assess 
FAK phosphorylation. We observed that PAR1 agonist pep-
tide increased FAK phosphorylation at tyrosine 397 and 576 
residues in WT lungs (  Fig. 7 A  ).   However, in lungs of   fyn       /         
mice, FAK phosphorylation at tyrosine 397 and 576 was barely 
detectable under basal conditions and did not increase after 
PAR1 activation (  Fig. 7 A  ), which is consistent with our 
fi  ndings in Fyn-depleted endothelial cells. Deletion of Fyn had 
no eff  ect on either cSrc expression or cSrc phosphorylation in-
duced by PAR1 (  Fig. 7 B  ), implicating Fyn as the key enzyme 
regulating FAK activation. 
  Next, we determined the microvessel fi  ltration coeffi   cient 
(K  f  ) in lungs isolated from WT and   fyn       /         mice. We showed 
that basal K  f   was signifi  cantly higher in   fyn       /         lungs than WT 
lungs (  Fig. 7 C  ). To confi  rm that deletion of Fyn in mouse 
lungs leads to pulmonary edema, we determined Evans blue 
albumin extravasation (EBAE) and lung wet-to-dry weight 
    Figure 5.     G    1–Fyn interaction is required for FAK activation.   (A)  G    1 is required for thrombin-induced Fyn phosphorylation. Lysates from HPAE 
cells transfected with either SiSc or SiG     1 were immunoprecipitated with anti-Fyn Ab after which they were immunoblotted with anti-phosphotyrosine 
Abs to determine Fyn phosphorylation. Lower immunoblot with anti-Fyn Ab was perfomed to verify equal protein loading. Depicted blots are typical of 
three similar experiments. (B) G     1 is required for inducing Fyn kinase activity on FAK. HPAE cells were transduced with SiSc, SiG     1, or SiRACK1, stimu-
lated with 50 nM thrombin for 10 min, and immunoprecipitated with anti-Fyn Ab, followed by incubation with protein AG beads. Protein complexes on 
beads were then incubated with purifi  ed recombinant FAK in a buffer containing ATP for determination of Fyn kinase activity on FAK in vitro. After 
30 min, the reaction was terminated by the addition of SDS sample buffer and FAK phosphorylation was determined using anti-phosphotyrosine Abs. 
Immuno  blot with anti-Fyn Ab was performed to confi  rm equal protein loading. Data represent results from experiments that were repeated at least two 
times. Results indicate that complex formation between G     1 and Fyn is required for Fyn kinase activity on FAK.     2768 G         reverses increased endothelial permeability   | Knezevic et al. 
phorylation at Y397 and Y576 to levels seen in vector control 
cells after thrombin stimulation.   Thrombin could not increase 
FAK phosphorylation further in cells transducing FAK phos-
phorylation mimicking mutant (  Fig. 9 A  ). 
  Next we transduced the same mutant construct into WT 
and   fyn       /         murine lung microvessels using cationic liposomes 
vascular permeability responses to PAR1 agonist to the level 
seen in WT mice. We replaced Tyr 397 and Tyr 576 with Asp 
and expressed the mutant construct in cultured endothelial cells. 
First, we confi  rmed that expression of FAK mutant Y397D/
Y576D increased FAK phosphorylation. As shown in   Fig. 9 A  , 
transduction of the mutant construct increased basal FAK phos-
    Figure 6.     Requirement for Fyn downstream of G    1 in inducing FAK activation and restoration of endothelial barrier function.   (A) Effect of 
Fyn knockdown on G     1–FAK interaction. HPAE cells were transfected with either control (Sc) or Fyn siRNA, stimulated with 50 nM thrombin for indicated 
times, and lysed. Immunoprecipitation was performed with anti-G     1 Ab, followed by immunoblotting with anti-FAK and anti-RACK1 Abs to determine 
interaction. (top) Immunoblot with anti-Fyn and anti-cSrc Abs that confi  rms the specifi  c knockdown of Fyn in cells transfected with SiFyn. Data represen-
tative of three experiments (  n   = 3). (B) Effect of Fyn knockdown on FAK phosphorylation. Lysates from HPAE cells transfected with either SiSc or SiFyn 
were immunoblotted with anti–phospho-Y397, anti–phospho-Y576, or anti-FAK Abs to determine FAK phosphorylation. Data represent mean ± SD from 
four experiments. * indicates signifi  cance (P < 0.05). (C) Effect of Fyn and cSrc knockdown on endothelial permeability. HPAE cells were stimulated with 50 
nM thrombin and changes in TER were measured over time. Representative traces (left) showing changes in TER in endothelial cell monolayer transfected 
with control (SiSc), cSrc (SiSrc), or Fyn (SiFyn) siRNA. Graph (right) gives mean ± SD of changes in TER from three independent experiments that were 
performed in duplicates. * indicates signifi  cance (P < 0.05).     JEM VOL. 206, November 23, 2009 
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  DISCUSSION 
  Thrombin, which is generated during vascular injury, acutely 
increases endothelial permeability by activating PAR1 on en-
dothelial cells (  Coughlin, 2000  ;   Landis, 2007  ;   McLaughlin 
et al., 2007  ;   Suzuki et al., 2009  ). PAR1 produces these eff  ects 
by stimulating dissociation of the heterotrimeric G protein 
complexes into functional G      and G           subunits (  Swift et al., 
2000  ;   Rahman et al., 2002  ;   McLaughlin et al., 2005  ). Several 
lines of evidence favor the conclusion that the dissociated 
G     q and G     12/G     13 subunit increases endothelial permea-
bility by signaling the activation of myosin light chain kinase 
and RhoA pathways, which in turn leads to endothelial cell 
contraction and disruption of cell–cell adhesion (  Dudek and 
Garcia, 2001  ;   Mehta et al., 2001  ;   Holinstat et al., 2003  ;   Singh 
et al., 2007  ;   Knezevic et al., 2007  ;   Singh et al., 2007  ;   Gavard 
and Gutkind, 2008  ;   Korhonen et al., 2009  ). However, such 
studies have not defi  ned the role of the released G           unit 
encapsulating GFP-tagged FAK-Y397D/-Y576D cDNA. 
We observed increased FAK phosphorylation in lungs of 
  fyn       /         (  Fig. 9, B and C  ) and WT mice (  Fig. 9 C  ). Immuno-
staining of lung sections from WT or Fyn-null mice express-
ing the FAK-Y397D/-Y576D mutant with anti–VE cadherin 
and phosphospecifi  c FAK antibodies showed that activated 
FAK was localized in pulmonary vascular endothelial cells 
(  Fig. 9 C  ). We next determined transvascular albumin per-
meability and lung edema formation in WT or   fyn       /         mice 
transduced with either control vector (GFP) or GFP-tagged 
FAK-Y397D/-Y576D cDNA. As shown in   Fig. 9 (D and E)  , 
transduction of FAK-Y397D/Y576D in the lungs signifi  -
cantly decreased albumin leakage and edema formation in re-
sponse to PAR1 activation in WT lungs. We also observed 
that restoring FAK phosphorylation reversed PAR-1–
induced lung vascular permeability in   fyn       /         lungs to the 
level observed in WT mice lungs (  Fig. 9, D and E  ). 
    Figure 7.     Fyn is required for limiting the increase in lung microvascular permeability.   (A and B) Fyn deletion prevents PAR1 activation of FAK 
phosphorylation. Lungs from C57BL/6 (WT) and   fyn      /       mice receiving control or PAR1 peptide (1 mg/kg) for indicated times were homogenized, and 
proteins immunoblotted with anti–phospho-Y397-FAK, anti–phospho-Y576-FAK, and anti-FAK Abs (A) or and anti–phospho-Y419Src and anti-cSrc Ab 
(B) to assess FAK (A) and Src (B) phosphorylation. Immunoblot with anti-Fyn and anti-cSrc show that deletion of Fyn (A) did not alter the expression of 
cSrc (B). Data representative of three independent experiments. (C) Changes in lung microvascular permeability in   fyn     /       mice. In isogravimetric lungs 
intravascular pressure was raised by 10 cm H  2  O for 20 min and microvessel fi  ltration coeffi  cient (K  f  ) was calculated from the slope of the weight gain 
function normalized by lung dry weight, as described in Materials and methods. Plot gives mean ± SD of four experiments. In each experiment   fyn      /      
lung was paired with WT lung. * indicates signifi  cance (P < 0.05). (D–E) PAR1 agonist peptide augments the increase in lung microvascular permeability in 
  fyn     /       mice. PAR-1 peptide (1 mg/kg) or control peptide was injected together with Evans blue albumin retroorbitally into mice (WT, grey column;   fyn     /     , 
black bar). After 30 min, Evans blue albumin extravasation (EBAE) from lungs or plasma (D) and lung wet/dry weight ratio (E) were determined as de-
scribed in Materials and methods to quantify lung microvascular protein permeability and lung edema formation, respectively. Data represent mean ± SD 
of four individual experiments where   fyn      /       lungs were paired with WT lungs. * indicates signifi  cance from appropriate control peptide group (P < 0.05); 
  #   indicates signifi  cance from WT mice after PAR1 challenge (P < 0.05).     2770 G         reverses increased endothelial permeability   | Knezevic et al. 
subunit from G           (  Cabrera-Vera et al., 2003  ;   Oldham and 
Hamm, 2008  ). Additionally, our data show that upon stimu-
lation the equilibrium is shifted away from the receptor, and 
defi  nitely from RACK1, favoring G           association with Fyn 
and FAK. However, our studies cannot delineate whether 
G           forms a single complex with RACK1 and Fyn/FAK 
or if these two form separate complexes. Thus, our fi  ndings 
suggest that RACK1 negatively regulates G     1 restoration of 
barrier function by preventing G     1–Fyn interaction and re-
stricting Fyn up-regulation of FAK activity. Supporting this 
conclusion are our fi  ndings that depletion of RACK1 en-
hanced G     1 interaction with Fyn, thereby stimulating Fyn 
activation of FAK activity, with the predictable consequences 
of counteracting PAR1-induced barrier dysfunction and of 
accelerating the recovery of barrier function to basal levels. 
The mechanism by which thrombin facilitates the dissocia-
tion of RACK1 from G     1 and Fyn is not clear. Evidence in-
dicates that RACK1 acts as a negative regulator of G     1 and 
Fyn (  Dell et al., 2002  ;   Thornton et al., 2004  ). G     1 and Fyn 
share binding sites on RACK1 (  Yaka et al., 2002  ;   Thornton 
et al., 2004  ), and in some studies RACK1 also heteromerizes 
with G     1 (  Dell et al. 2002  ). PKC and phosphatases such as 
SHIP were shown to modify RACK1 function by inducing 
its posttranslational modifi  cation (  Ron et al., 1994  ;   Nishio 
et al., 2007  ). Because thrombin activates PKC and SHIP 
(  Mehta et al., 2001  ;   Tiruppathi et al., 2002  ;   Dyson et al., 
2003  ), a possible scenario is that posttranslational modifi  ca-
tion of RACK1 decreases the affi   nity of RACK1 for Fyn and 
G     1, thus enabling them to interact with FAK to signal bar-
rier restoration. 
  Our data also showed that the permeability increasing ef-
fects of thrombin partially overlapped with the process of 
barrier recovery such that the 10-min time point refl  ects both 
processes, whereas the 30-min time points predominantly re-
fl  ect recovery. It is therefore possible that G          -Fyn signaling 
may serve to protect against the “acute” phase of thrombin-
induced permeability. However, we showed that FAK activ-
ity increased at 10 min, reached a maximum at 30 min, and 
persisted for 2 h. Interfering with G           or Fyn function in-
hibited FAK phosphorylation as early as 10 min, and there-
fore at all succeeding time points, and also prevented barrier 
recovery to basal levels. These results indicate the importance 
of G          -Fyn signaling in FAK-dependent reannealing of en-
dothelial junctions. 
  We found that activated PAR1 failed to induce phosphory-
lation of FAK at tyrosine residues 397 and 576 in Fyn knock-
down cells and in   fyn       /         lung preparations. However, Fyn 
deletion did not alter thrombin-induced p60cSrc phosphoryla-
tion. These fi  ndings implied that Fyn is required for FAK activa-
tion in endothelial cells. Studies showed that several members of 
the Src family of tyrosine kinases, including Fyn, can activate 
FAK (  Xing et al., 1994  ;   Bockholt and Burridge, 1995  ;   Thomas 
and Brugge, 1997  ;   Schaller, 2001  ;   Brunton et al., 2005  ;   Mitra 
and Schlaepfer, 2006  ). In this regard, our experimental observa-
tions that expression of p60cSrc, as well as p60Src phosphoryla-
tion, was normal in Fyn-depleted endothelial cells, and Fyn-null 
under these conditions. Impairing G           function using CT-
     ARK1 or G     1 siRNA allowed us to address the functional 
role of G           in the mechanism of PAR1-induced increase in 
endothelial permeability. These results showed that inhibi-
tion of G           did not augment thrombin-induced increase in 
endothelial permeability because of dysregulation of       subunit 
activity, and hence exacerbated RhoA signaling (  Holinstat 
et al., 2003  ;   Holinstat et al., 2006  ;   Mehta and Malik, 2006  ), but 
prevented recovery of endothelial barrier function. We also 
showed that direct stimulation of G           by mSIRK, bypassing 
the      -subunit activation, accelerated the recovery of endo-
thelial barrier function after thrombin challenge. Thus, G           
functions to promote recovery of barrier function through 
orchestration of signaling involving Fyn activation of FAK. 
  Studies show that fi  ve G      isoforms exist in various cell types 
(  Schwindinger and Robishaw, 2001  ;   Robishaw and Berlot, 
2004  ;   Thompson et al., 2008  ). However, our data show that 
G     1 is the predominant isoform expressed in human endothelial 
cells. Because G      dimerization with G      is required for the di-
mer to function (  Jones et al. 2004  ), we showed that targeted 
suppression of endogenous G     1 (    80%) prolonged the increase 
in permeability caused by thrombin, as contrasted with full re-
covery normally seen within 2 h in control cells. Together, these 
fi  ndings further support the conclusion that the primary func-
tion of G           is to restore endothelial barrier function. 
  G     1 belongs to a large family of WD40 repeat proteins 
and interacts with several proteins, including RACK1 (  Chen 
et al., 2004b  ). RACK1 also binds Fyn (  Yaka et al., 2002  ). 
Fyn induces FAK activity by phosphorylating Y397 and 
Y576 residues in FAK. We have shown that thrombin in-
duces a sustained phosphorylation of FAK at Y397 and Y576 
(  Holinstat et al., 2006  ). We also showed that activation of 
FAK is required to reverse the increase in endothelial perme-
ability (  Holinstat et al., 2006  ). Thus, we considered a model 
in which G     1 interacts with Fyn, inducing Fyn activation, 
which in turn up-regulates FAK activity, subsequently re-
storing endothelial barrier function. We noted that under 
basal conditions G     1 coimmunoprecipitated with RACK1 
and Fyn, but not FAK. The results of this study further 
showed that thrombin induced the interaction between G     1, 
Fyn, and FAK, coinciding with Fyn and FAK activation and 
restoration of endothelial barrier function. However, the for-
mation of this ternary complex required dissociation of G     1 
from RACK1 because knockdown of RACK1 enhanced 
interaction between G     1, Fyn, and FAK in the absence of 
thrombin stimulation and augmented FAK activity. Also, 
G     1, but not RACK1, was required for Fyn activation, 
which in turn induced FAK activity. We also showed that 
G     1 failed to interact with FAK in Fyn-depleted cells. Our 
data show that there is a basal interaction between G          , Fyn, 
and RACK1. We interpret these fi  ndings to mean that G           
exists in a dynamic equilibrium with RACK1, Fyn, and 
PAR1 receptor. Thrombin stimulation results in an increased 
association of G           with Fyn and FAK at the expense of re-
lease of G           from RACK1, and presumably from the PAR1 
receptor, as GPCR activation leads to dissociation of G      JEM VOL. 206, November 23, 2009 
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    Figure 8.     Fyn facilitates the association of FAK with AJ.   (A) FAK associates with p120 catenin. Lungs from WT or   fyn     /       mice receiving control or 
PAR1 peptide for indicated times, were homogenized and lysates were immunoprecipitated with anti-FAK Abs, followed by immunoblotting with p120-
catenin Ab. Data are representative of three independent experiments. (B and C) FAK colocalizes with p120-catenin. HPAE cells grown to confl  uence on 
coverslips were left unstimulated (a–c) or stimulated with 50 nM thrombin for 10 min (d–f), 30 min (g–i), or 120 min (j–l) and costained with anti–p120-
catenin (red) and anti-FAK (green) antibodies to determine colocalization. Results are representative of at least three separate experiments. (C) Mean ± SD 
of four experiments. * indicate signifi  cant increase in colocalization between phosphoFAK and p120-catenin (P < 0.05).     2772 G         reverses increased endothelial permeability   | Knezevic et al. 
    Figure 9.  Transduction of phosphorylation mimicking FAK mutant rescues lung microvascular permeability in   fyn      /        mice.   (A) HPAE cells 
transducing control vector (GFP) or GFP-tagged FAK Y397D/Y576D mutants were left unstimulated or stimulated with thrombin for 10 min. Cell lysates 
were immunoblotted with Y397 or Y756 residue specifi  c phospho-FAK antibodies or pan anti-FAK Abs to determine FAK phosphorylation. Mean ± SD 
represent values from three separate experiments. (B–E)   fyn     /       and/or WT mice were injected with liposomes conjugated with either GFP-tagged phos-
phorylation mimicking mutant (FAK-Y397D/Y576D) or GFP via retroorbital injection. (B) Immunoblot showing expression of phosphomimicking FAK JEM VOL. 206, November 23, 2009 
Article
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  Our fi   ndings also demonstrate the contrasting roles of 
p60cSrc and Fyn in regulating endothelial permeability. We 
showed that knockdown of p60cSrc suppressed the increase 
in endothelial permeability induced by PAR1. These fi  ndings 
are consistent with the observations in p60cSrc-null mice that 
were protected from VEGF-induced vascular leak (  Eliceiri 
et al., 1999  ). However, Fyn knockdown resulted in a persistent 
increase in endothelial permeability. Because we showed that 
basal pulmonary microvascular permeability is markedly in-
creased in   fyn       /         mouse lungs, it is indicated that activation of 
FAK regulates basal endothelial barrier function in vivo, as 
previously described (  Holinstat et al., 2006  ). We also showed 
that Fyn was required for suppressing the lung vascular per-
meability increase after PAR1 activation because   fyn       /         lungs 
failed to recover and therefore developed persistent edema. 
We conclude that the absence of FAK activation in the endo-
thelium of   fyn       /         lungs impaired endothelial barrier function. 
This scenario is likely because the transduction of a phospho-
mimicking FAK mutant rescued lung vascular function in 
  fyn       /         lungs to near normal values. Thus, these fi  ndings dem-
onstrate that G          -Fyn dependent pathway for activation of 
FAK stimulates reannealing of junctions. Additionally, studies 
have shown that activation of SPHK1 is required for restoring 
endothelial barrier function (  Li et al., 2008  ;   Tauseef et al., 
2008  ). Whether these two pathways act in concert remains to 
be investigated, but it is likely that multiple mechanisms are 
engaged to correct endothelial barrier defects. 
lungs showed that p60cSrc could not substitute for Fyn in in-
ducing FAK activation. 
  Because FAK organizes focal adhesions, a likely scenario 
could be that FAK restores endothelial barrier function by its 
eff  ect on cell–ECM interaction. Intriguingly, our data show 
that a pool of FAK colocalized with the AJ marker p120-
catenin under basal conditions, and colocalization increased 
further when the endothelial barrier function was restored. 
FAK activation or junctional reassembly was not evident 
when endogenous expression of Fyn was suppressed. More-
over, PAR1 stimulation in lungs from Fyn  -  defi  cient mice did 
not induce FAK activation, or FAK interaction with p120-
catenin, and thus induced an exaggerated lung vascular per-
meability increase. Studies show that p120-catenin is required 
for maintaining AJ integrity and for repairing the endothelial 
barrier (  Iyer et al., 2004  ;   Mehta and Malik, 2006  ;   Dejana 
et al., 2008  ;   Rudini and Dejana, 2008  ). Our fi  ndings that in-
teraction of activated FAK with p120-catenins subsequent to 
Fyn activation of FAK facilitates reannealing of AJ leading to 
reestablishment of the basal endothelial barrier suggest that 
the Fyn–FAK pathway plays a critical role in restoring endo-
thelial barrier function. We have demonstrated that tyrosine 
phosphorylation of p190RhoGAP by FAK is crucial in 
down-regulating RhoA activity, which in turn facilitates the 
restoration of barrier function after thrombin challenge 
(  Holinstat et al., 2006  ). The fi  ndings of this study indicate that 
FAK can also interact with AJ components and reanneal AJ. 
mutant in   fyn     /       mice. Lysates from lungs transduced with GFP or GFP-tagged FAK-Y397D/Y576D mutant were immunoblotted with anti-phospho-Y397 
anti-FAK Abs. Immunoblot represent data from at least two independent experiments. (C) Confocal images of lungs showing expression of GFP or GFP-
tagged FAK-Y397D/Y576D mutant in pulmonary vessels. Lungs transduced with GFP or GFP-tagged FAK-Y397D/Y576D mutant were sectioned and co-
immunostained with anti–Y397-phospho-FAK or VE-cadherin to determine whether mutants are expressed in endothelium. Images represent results from 
experiments that were performed independently at least twice. (D and E) Effect of transduction of FAK-Y397D/Y576D mutant on PAR1-induced lung vas-
cular permeability. WT or   fyn     /       mice expressing indicated mutants received PAR1 peptide i.v. along with Evans blue albumin to determine protein perme-
ability. Lung wet/dry weight ratio was also determined as described in Materials and methods. Data represent mean ± SD of four experiments done paired 
wise. * indicates signifi  cance from control group (P < 0.05). All experiments were performed 48 h after injection of liposome encapsulated mutants.     
 
    Figure 10.  Model of G         -mediated adherens junction assembly.   After increases in endothelial permeability via G     q and G    12/13  pathways, 
thrombin dissociates RACK1 from G     1, enabling it to interact with Fyn that leads to Fyn activation. Fyn phosphorylates FAK which localizes to intercel-
lular junctions where it induces reannealing of AJ. FAK also associates with p190RhoGAP (not depicted), which suppresses endothelial contraction by 
down-regulating RhoA activity. Together, these events promote stabilization of cell–ECM attachment and intercellular adhesion resulting in the restora-
tion of endothelial permeability.     2774 G         reverses increased endothelial permeability   | Knezevic et al. 
used for semiquantitative RT-PCR to assess the expression of G     1, G     2, 
G     3, G     4, and G     5 subunits using primers designed for the human mRNA 
sequences (Santa Cruz Biotechnology, Inc.) with the aid of the Invitrogen 
SuperScript RT-PCR kit. We used the following conditions: an initial 94°C 
denaturing for 2 min, followed by 25 cycles at 95°C for 15 s each, annealing 
at 55°C for 30 s, and extension at 72°C for 30 s. The last cycle was followed 
by a 7-min reaction at 72°C. RT-PCR products were separated by electro-
phoresis on a 2% agarose gel. 
  Coimmunoprecipitation.     HPAE cells grown in 100-mm dishes were 
lysed and equal amounts of protein were immunoprecipitated with appro-
priate Abs overnight at 4°C, followed by the addition of protein A/G aga-
rose beads for 4 h at 4°C, as described previously (  Holinstat et al., 2006  ). 
  In vitro kinase assay.     HPAE cells transduced with appropriate siRNA 
were stimulated with thrombin for the indicated times. Lysates were and 
immunoprecipitated with anti-Fyn Ab, followed by incubation with protein 
A/G agarose beads to form immunocomplexes. Immunocomplexes were 
used for determining Fyn in vitro kinase activity, using purifi  ed FAK as the 
substrate as previously described (  Holinstat et al., 2006  ). 
  RhoGTPase activity.     HPAE cells transducing indicated cDNA were stimu-
lated with 50 nM thrombin, and RhoA activity was measured using the GST-
rhotekin-Rho binding domain, as previously described (  Holinstat et al., 2006  ). 
  Immunofl  uorescence.     Cells transduced with cDNA or siRNA were stim-
ulated with 50 nM thrombin for the indicated times, fi  xed, and stained with 
appropriate Abs, as previously described (  Knezevic et al., 2007  ;   Singh et al., 
2007  ). Cells were visualized with 63× 1.2 NA objective on a LSM 510 con-
focal microscope (Carl Zeiss, Inc.). Interendothelial gap area was quantifi  ed 
using a MetaMorph software (Molecular Devices). 
  Endothelial permeability assessment.     For TER measurements, HPAE 
cells were seeded on 8-well gold-coated electrodes, where they formed con-
fl  uent monolayers. TER is expressed as specifi  c electrical resistance (Ω cm  2  ; 
  Mehta et al., 2002  ). Albumin permeability of HPAE monolayers grown on 
transwell plates was measured by quantifying the fl  ux of Evans blue–labeled 
albumin (EBA) from luminal to abluminal chamber (  Tauseef et al., 2008  ). 
  Liposomal delivery of cDNA in the mouse lung.     Cationic liposomes 
were made using a mixture of dimethyldioctadecyl-ammonium bromide and 
cholesterol in chloroform, as described previously (  Holinstat et al., 2006  ). GFP 
or GFP-FAK-Y397D/Y576D (50 μg) were mixed with 100 μl of liposomes. 
The mixture of liposomes and cDNA were injected intravenously (via retro-
orbital injection) into WT or   fyn       /         mice. After 48 h, mouse lungs were used 
for determining lung microvascular permeability or protein expression. 
  Immunohistochemistry.     Formalin fi  xed 4-μm-thick lung sections were 
immunostained with appropriate Abs using manufacture protocol (Bethyl 
Laboratories). Lung sections were visualized with a LSM510 confocal micro-
scope (Carl Zeiss, Inc.). 
  Assessment of lung capillary leakage.     EBA (20 mg/kg) was injected 
retroorbitally 30 min before sacrifi  ce to assess vascular leak, as previously de-
scribed (  Peng et al., 2004  ;   Tauseef et al., 2008  ). Blood was collected from 
the right ventricle into heparinized syringes and plasma was separated by 
centrifugation at 1,300   g   for 10 min. Lungs homogenates were prepared as 
previously described (  Tauseef et al., 2008  ). Lung homogenates and plasma 
were incubated with 2 volumes of formamide (18 h, 60°C), centrifuged at 
5,000   g   for 30 min, and the optical density of the supernatant was deter-
mined spectrophotometrically at 620 and 740 nm (to correct for hemoglo-
bin). EBA extravasation is given as lung/plasma ratio. 
  Pulmonary microvascular permeability.       Fyn       /         and WT mice were 
anesthetized with an i.p. injection of ketamine (100 mg/kg) and xylazine 
  In conclusion, our results indicate that G           plays an essential 
role in preventing the PAR1-induced long-lived increase in en-
dothelial permeability. We propose a model whereby thrombin-
mediated dissociation of RACK1 from G           results in G           and 
Fyn complex formation that leads to Fyn activation and phos-
phorylation of FAK (  Fig. 10  ).   A pool of activated FAK interacts 
with p120 catenin, where it induces reannealing of AJ down-
stream of Fyn. FAK also associates with p190RhoGAP ( Holinstat 
et al., 2006  ) which suppresses endothelial contraction by down-
regulating RhoA activity. Together, these events promote stabi-
lization of cell–ECM attachment and intercellular adhesion, 
resulting in the restoration of endothelial permeability. Develop-
ment of targets that specifi  cally modify this pathway could there-
fore lead to therapeutic strategies to protect against persistent 
lung vascular barrier leakiness. 
  MATERIALS AND METHODS 
  Materials.     HPAE cells and endothelial growth medium (EBM-2) were 
obtained from Lonza. Human      -thrombin was obtained from Enzyme 
Research Laboratories. Nucleofector kit and electroporation system were 
obtained from Lonza. Superfect transfection reagent was purchased from 
QIAGEN. Alexa Fluor–phallodin, anti–Alexa Fluor–568 and –488 anti-
bodies, DAPI, and ProLong Gold antifade were obtained from Invitrogen. 
Electrodes for transendothelial resistance measurements were obtained from 
Applied Biosciences. 12-mm-diam transwell plates and 0.4-μm polyester 
membranes were purchased from Corning. Primers for G      1–5 subunits, 
siRNA for G     1, Fyn, cSrc, and control scrambled siRNA, as well as trans-
fection reagent for siRNA, were purchased from Santa Cruz Biotechnology, 
Inc. RACK1 siRNA (5     -CCAUCAAGCUAUGGAAUACTT-3      sense 
and 5     -GUAUUCCAUAGCUUGAUGGTT-3      antisense) were purchased 
from Sigma-Aldrich. Anti-FAK, anti–phospho FAK PY576, anti-RhoA, 
anti-RACK1, anti-G     1, anti-Fyn, anti-cSrc, anti-VE-cadherin, anti-GRK2, 
anti-GFP, anti-p120, anti-phosphotyrosine Abs (PY20, PY99, and PY350), 
and protein A/G agarose beads were purchased from Santa Cruz Biotech-
nology, Inc. Anti–phospho FAK PY397 was purchased from Invitrogen, 
anti–      catenin Ab was obtained from Abcam. mSIRK and mSIRK-L9A 
were purchased from Calbiochem. GST-rhotekin-Rho binding domain beads 
were purchased from Cytoskeleton. Ad-CT-     ARK (C terminus of      -
adrenoreceptor kinase) was a gift from R. Minshall (University of Illinois, 
Chicago, IL, and GFP-tagged G     1 and G     2 were gifts from J. McLaughlin 
(University of Illinois, Chicago, IL). 
  Animals.     All animal studies were approved by the Institutional Animal Care 
and Use Committee of the University of Illinois.   fyn       /         male mice obtained 
from The Jackson Laboratory were backcrossed to C57BLk/6J background. 
C57BLk/6J mice were used as WT controls. All experiments were per-
formed on 6–8-wk-old male mice. 
  Endothelial cell culture.     HPAE cells were cultured as previously described 
(  Knezevic et al., 2007  ;   Singh et al., 2007  ). 
  Transfection of cells.     siRNA or cDNA were transduced into cells by 
electroporation or using transfection reagents, as previously described (  Singh 
et al., 2007  ). For adenoviral vector-mediated gene transduction, cells grown 
to confl  uence were infected with Ad-control vector or Ad-CT-     ARK in 
serum-free medium. 6 h after infection, the medium was replaced with fresh 
complete medium without virus. In all experiments, cells were used between 
32 and 36 h after virus infection. Control vector (Ad-control vector) or Ad-
CT-     ARK was generated as previously described (  Drazner et al., 1997  ). 
  RT-PCR.     Total RNA was isolated from HPAE cells with Trizol reagent 
(Invitrogen) according to the manufacturer’s instructions. RNA (1 μg) was JEM VOL. 206, November 23, 2009 
Article
2775
      Dell  ,  E.J.  ,  J.    Connor  ,  S.    Chen  ,  E.G.    Stebbins  ,  N.P.    Skiba  ,  D.    Mochly-Rosen  , 
and   H.E.     Hamm  .   2002  .   The betagamma subunit of heterotrimeric G 
proteins interacts with RACK1 and two other WD repeat proteins.       
J. Biol. Chem.       277  :  49888  –  49895  .   doi:10.1074/jbc.M202755200     
      Drazner  ,   M.H.  ,   K.C.     Peppel  ,   S.     Dyer  ,   A.O.     Grant  ,   W.J.     Koch  , and   R.J.   
  Lefkowitz  .   1997  .   Potentiation of beta-adrenergic signaling by adenovi-
ral-mediated gene transfer in adult rabbit ventricular myocytes.       J. Clin. 
Invest.       99  :  288  –  296  .   doi:10.1172/JCI119157     
      Dudek  ,   S.M.  , and   J.G.     Garcia  .   2001  .   Cytoskeletal regulation of pulmonary 
vascular permeability.       J. Appl. Physiol.       91  :  1487  –  1500  .   
      Dyson  ,   J.M.  ,   A.D.     Munday  ,   A.M.     Kong  ,   R.D.     Huysmans  ,   M.     Matzaris  , 
  M.J.     Layton  ,   H.H.     Nandurkar  ,   M.C.     Berndt  , and   C.A.     Mitchell  .   2003  . 
  SHIP-2 forms a tetrameric complex with fi  lamin, actin, and GPIb-IX-
V: localization of SHIP-2 to the activated platelet actin cytoskeleton.   
    Blood      .     102  :  940  –  948  .   doi:10.1182/blood-2002-09-2897     
      Eliceiri  ,   B.P.  ,   R.     Paul  ,   P.L.     Schwartzberg  ,   J.D.     Hood  ,   J.     Leng  , and   D.A.   
  Cheresh  .   1999  .   Selective requirement for Src kinases during VEGF-
induced angiogenesis and vascular permeability.       Mol. Cell      .     4  :  915  –  924  . 
  doi:10.1016/S1097-2765(00)80221-X     
      Gavard  ,   J.  , and   J.S.     Gutkind  .   2008  .   Protein kinase C-related kinase and 
ROCK are required for thrombin-induced endothelial cell perme-
ability downstream from Galpha12/13 and Galpha11/q.       J. Biol. Chem.     
  283  :  29888  –  29896  .   doi:10.1074/jbc.M803880200     
      Goeckeler  ,   Z.M.  , and   R.B.     Wysolmerski  .   1995  .   Myosin light chain kinase-
regulated endothelial cell contraction: the relationship between isomet-
ric tension, actin polymerization, and myosin phosphorylation.       J. Cell 
Biol.       130  :  613  –  627  .   doi:10.1083/jcb.130.3.613     
      Goubaeva  ,   F.  ,   M.     Ghosh  ,   S.     Malik  ,   J.     Yang  ,   P.M.     Hinkle  ,   K.K.     Griendling  , 
  R.R.     Neubig  , and   A.V.     Smrcka  .   2003  .   Stimulation of cellular signaling 
and G protein subunit dissociation by G protein betagamma subunit-
binding peptides.       J. Biol. Chem.       278  :  19634  –  19641  .   doi:10.1074/jbc
.M300052200     
      Herlitze  ,   S.  ,   D.E.     Garcia  ,   K.     Mackie  ,   B.     Hille  ,   T.     Scheuer  , and   W.A.   
  Catterall  .   1996  .   Modulation of Ca2+ channels by G-protein beta 
gamma subunits.       Nature      .     380  :  258  –  262  .   doi:10.1038/380258a0     
      Holinstat  ,   M.  ,   D.     Mehta  ,   T.     Kozasa  ,   R.D.     Minshall  , and   A.B.     Malik  .   2003  . 
  Protein kinase Calpha-induced p115RhoGEF phosphorylation signals 
endothelial cytoskeletal rearrangement.     J. Biol. Chem.      278  :  28793  –  28798  .   
doi:10.1074/jbc.M303900200     
      Holinstat  ,   M.  ,   N.     Knezevic  ,   M.     Broman  ,   A.M.     Samarel  ,   A.B.     Malik  , and 
  D.     Mehta  .   2006  .   Suppression of RhoA activity by focal adhesion 
kinase-induced activation of p190RhoGAP: role in regulation of endo-
thelial permeability.       J. Biol. Chem.       281  :  2296  –  2305  .   doi:10.1074/jbc
.M511248200     
      Hung  ,   D.T.  ,   Y.H.     Wong  ,   T.K.     Vu  , and   S.R.     Coughlin  .   1992  .   The cloned 
platelet thrombin receptor couples to at least two distinct eff  ectors to 
stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase.     J. Biol. 
Chem.       267  :  20831  –  20834  .   
      Hurowitz  ,   E.H.  ,   J.M.     Melnyk  ,   Y.J.     Chen  ,   H.     Kouros-Mehr  ,   M.I.     Simon  , 
and   H.     Shizuya  .   2000  .   Genomic characterization of the human hetero-
trimeric G protein alpha, beta, and gamma subunit genes.       DNA Res.     
  7  :  111  –  120  .   doi:10.1093/dnares/7.2.111     
      Iyer  ,  S.  ,  D.M.    Ferreri  ,  N.C.    DeCocco  ,  F.L.    Minnear  , and  P.A.    Vincent  .  2004  . 
  VE-cadherin-p120 interaction is required for maintenance of endothelial 
barrier function.     Am. J. Physiol. Lung Cell. Mol. Physiol.      286  :  L1143  –  L1153  . 
  doi:10.1152/ajplung.00305.2003     
      Jin  ,  T.  ,  N.    Zhang  ,  Y.    Long  ,  C.A.    Parent  , and  P.N.    Devreotes  .  2000  .  Localization 
of the G protein betagamma complex in living cells during chemotaxis.   
    Science      .     287  :  1034  –  1036  .   doi:10.1126/science.287.5455.1034     
      Jones  ,   M.B.  ,   D.P.     Siderovski  , and   S.B.     Hooks  .   2004  .   The G betagamma 
dimer as a novel source of selectivity in G-protein signaling: GGL-ing 
at convention.       Mol. Interv.       4  :  200  –  214  .   doi:10.1124/mi.4.4.4     
      Kaneider  ,   N.C.  ,   A.J.     Leger  ,   A.     Agarwal  ,   N.     Nguyen  ,   G.     Perides  ,   C.     Derian  , 
  L.     Covic  , and   A.     Kuliopulos  .   2007  .   ‘Role reversal’ for the receptor 
PAR1 in sepsis-induced vascular damage.       Nat. Immunol.       8  :  1303  –  1312  . 
  doi:10.1038/ni1525     
      Kataoka  ,   H.  ,   J.R.     Hamilton  ,   D.D.     McKemy  ,   E.     Camerer  ,   Y.W.     Zheng  , 
  A.     Cheng  ,   C.     Griffi   n  , and   S.R.     Coughlin  .   2003  .   Protease-activated 
(2.5 g/kg). Microvessel permeability in the lung was measured by determining 
microvascular fi  ltration coeffi   cient (K  f  ) and isogravimetric lung water determi-
nations as previously described (  Vogel et al. 2000  ;   Holinstat et al. 2006  ). 
  Lung weight determination.     Left lungs from the same mice used for Evans 
blue albumin extravasation were excised and completely dried in the oven at 
60°C overnight for calculation of lung wet/dry ratio (  Barnard et al. 1995  ). 
  Statistical analysis  .       Comparisons between experimental groups were made 
by one-way ANOVA and post-hoc test. Diff  erences in mean values were 
considered signifi  cant at P < 0.05. 
  We acknowledge Drs. Asrar B. Malik and Stephen M. Vogel for their constructive 
criticism during the preparation of this manuscript; Yulia Komarova for her advice 
in analysis of interendothelial gap formation; Tiffany Sharma and Debra Salvi for 
constructing FAKY387D/Y576D mutant; and Ms. Vidisha Kini for technical help. We 
also thank Dr. Xiaoping Dufor his gift of   fyn     /       mice. 
  This work was supported by National Institutes of Health grants HL71794 
and HL84153. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   23 March 2009 
Accepted:   14 October 2009 
  REFERENCES 
      Barnard  ,   J.W.  ,   M.G.     Biro  ,   S.K.     Lo  ,   S.     Ohno  ,   M.A.     Carozza  ,   M.     Moyle  , 
  H.R.     Soule  , and   A.B.     Malik  .   1995  .   Neutrophil inhibitory factor pre-
vents neutrophil-dependent lung injury.       J. Immunol.       155  :  4876  –  4881  .   
      Blackmer  ,   T.  ,   E.C.     Larsen  ,   M.     Takahashi  ,   T.F.     Martin  ,   S.     Alford  , and   H.E.   
  Hamm  .   2001  .   G protein betagamma subunit-mediated presynaptic in-
hibition: regulation of exocytotic fusion downstream of Ca2+ entry.   
    Science      .     292  :  293  –  297  .   doi:10.1126/science.1058803     
      Blackmer  ,   T.  ,   E.C.     Larsen  ,   C.     Bartleson  ,   J.A.     Kowalchyk  ,   E.J.     Yoon  ,   A.M.   
  Preininger  ,   S.     Alford  ,   H.E.     Hamm  , and   T.F.     Martin  .   2005  .   G protein 
betagamma directly regulates SNARE protein fusion machinery for se-
cretory granule exocytosis.       Nat. Neurosci.       8  :  421  –  425  .   
      Bockholt  ,   S.M.  , and   K.     Burridge  .   1995  .   An examination of focal adhesion 
formation and tyrosine phosphorylation in fi   broblasts isolated from 
src-, fyn-, and yes- mice.       Cell Adhes. Commun.       3  :  91  –  100  .   doi:10.3109/
15419069509081279     
      Brunton  ,   V.G.  ,   E.     Avizienyte  ,   V.J.     Fincham  ,   B.     Serrels  ,   C.A.     Metcalf     III  ,   T.K.   
  Sawyer  , and   M.C.     Frame  .   2005  .   Identifi  cation of Src-specifi  c phosphory-
lation site on focal adhesion kinase: dissection of the role of Src SH2 and 
catalytic functions and their consequences for tumor cell behavior.       Cancer 
Res.       65  :  1335  –  1342  .   doi:10.1158/0008-5472.CAN-04-1949     
      Cabrera-Vera  ,   T.M.  ,   J.     Vanhauwe  ,   T.O.     Thomas  ,   M.     Medkova  ,   A.   
  Preininger  ,   M.R.     Mazzoni  , and   H.E.     Hamm  .   2003  .   Insights into G 
protein structure, function, and regulation.       Endocr. Rev.       24  :  765  –  781  . 
  doi:10.1210/er.2000-0026     
      Chen  ,   S.  ,   E.J.     Dell  ,   F.     Lin  ,   J.     Sai  , and   H.E.     Hamm  .   2004a  .   RACK1 regulates 
specifi  c functions of Gbetagamma.       J. Biol. Chem.       279  :  17861  –  17868  . 
  doi:10.1074/jbc.M313727200     
      Chen  ,   S.  ,   B.D.     Spiegelberg  ,   F.     Lin  ,   E.J.     Dell  , and   H.E.     Hamm  .   2004b  . 
  Interaction of Gbetagamma with RACK1 and other WD40 repeat proteins.  
    J. Mol. Cell. Cardiol.       37  :  399  –  406  .   doi:10.1016/j.yjmcc.2004.04.019     
      Clapham  ,   D.E.  , and   E.J.     Neer  .   1997  .   G protein beta gamma subunits.       Annu. 
Rev. Pharmacol. Toxicol.       37  :  167  –  203  .   doi:10.1146/annurev.pharmtox
.37.1.167     
      Coughlin  ,   S.R.     1999  .   How the protease thrombin talks to cells.       Proc. Natl. 
Acad. Sci. USA      .     96  :  11023  –  11027  .   doi:10.1073/pnas.96.20.11023     
      Coughlin  ,   S.R.     2000  .   Thrombin signalling and protease-activated receptors.   
    Nature      .     407  :  258  –  264  .   doi:10.1038/35025229     
      Coughlin  ,   S.R.     2005  .   Protease-activated receptors in hemostasis, thrombosis 
and vascular biology.       J. Thromb. Haemost.       3  :  1800  –  1814  .   doi:10.1111/
j.1538-7836.2005.01377.x     
      Dejana  ,   E.  ,   F.     Orsenigo  , and   M.G.     Lampugnani  .   2008  .   The role of adherens 
junctions and VE-cadherin in the control of vascular permeability.   
    J. Cell Sci.       121  :  2115  –  2122  .   doi:10.1242/jcs.017897     2776 G         reverses increased endothelial permeability   | Knezevic et al. 
cleotide exchange factor for RhoA and Rac1: regulation of cell shape and 
reactive oxygen species production.     Circ. Res.      93  :  848  –  856  .  doi:10.1161/
01.RES.0000097607.14733.0C     
      Oldham  ,   W.M.  , and   H.E.     Hamm  .   2008  .   Heterotrimeric G protein activa-
tion by G-protein-coupled receptors.       Nat. Rev. Mol. Cell Biol.       9  :  60  –  71  . 
  doi:10.1038/nrm2299     
      Owens  ,   D.W.  ,   G.W.     McLean  ,   A.W.     Wyke  ,   C.     Paraskeva  ,   E.K.     Parkinson  , 
  M.C.     Frame  , and   V.G.     Brunton  .   2000  .   The catalytic activity of the Src 
family kinases is required to disrupt cadherin-dependent cell-cell con-
tacts.       Mol. Biol. Cell      .     11  :  51  –  64  .   
      Peng  ,   X.  ,   P.M.     Hassoun  ,   S.     Sammani  ,   B.J.     McVerry  ,   M.J.     Burne  ,   H.     Rabb  , 
  D.     Pearse  ,   R.M.     Tuder  , and   J.G.     Garcia  .   2004  .   Protective eff  ects of 
sphingosine 1-phosphate in murine endotoxin-induced infl  ammatory 
lung injury.       Am. J. Respir. Crit. Care Med.       169  :  1245  –  1251  .   doi:10.1164/
rccm.200309-1258OC     
      Piedra  ,   J.  ,   S.     Miravet  ,   J.     Castaño  ,   H.G.     Pálmer  ,   N.     Heisterkamp  ,   A.     García 
de Herreros  , and   M.     Duñach  .   2003  .   p120 Catenin-associated Fer and 
Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and 
beta-catenin-alpha-catenin Interaction.       Mol. Cell. Biol.       23  :  2287  –  2297  . 
  doi:10.1128/MCB.23.7.2287-2297.2003     
      Rahman  ,   A.  ,   A.L.     True  ,   K.N.     Anwar  ,   R.D.     Ye  ,   T.A.     Voyno-Yasenetskaya  , 
and   A.B.     Malik  .   2002  .   Galpha(q) and Gbetagamma regulate PAR-1 sig-
naling of thrombin-induced NF-kappaB activation and ICAM-1 tran-
scription in endothelial cells.       Circ. Res.       91  :  398  –  405  .   doi:10.1161/01.
RES.0000033520.95242.A2     
      Robishaw  ,   J.D.  , and   C.H.     Berlot  .   2004  .   Translating G protein subunit di-
versity into functional specifi  city.       Curr. Opin. Cell Biol.       16  :  206  –  209  . 
  doi:10.1016/j.ceb.2004.02.007     
      Ron  ,   D.  ,   C.H.     Chen  ,   J.     Caldwell  ,   L.     Jamieson  ,   E.     Orr  , and   D.     Mochly-
Rosen  .   1994  .   Cloning of an intracellular receptor for protein kinase C: 
a homolog of the beta subunit of G proteins.       Proc. Natl. Acad. Sci. USA      .   
  91  :  839  –  843  .   doi:10.1073/pnas.91.3.839     
      Roura  ,  S.  ,  S.    Miravet  ,  J.    Piedra  ,  A.    García de Herreros , and  M.    Duñach  .  1999  . 
  Regulation of E-cadherin/Catenin association by tyrosine phosphoryla-
tion.       J. Biol. Chem.       274  :  36734  –  36740  .   doi:10.1074/jbc.274.51.36734     
      Rudini  ,   N.  , and   E.     Dejana  .   2008  .   Adherens junctions.       Curr. Biol.       18  :  R1080  –
  R1082  .   doi:10.1016/j.cub.2008.09.018     
      Schaller  ,   M.D.     2001  .   Biochemical signals and biological responses elic-
ited by the focal adhesion kinase.       Biochim. Biophys. Acta      .     1540  :  1  –  21  . 
  doi:10.1016/S0167-4889(01)00123-9     
      Schwindinger  ,   W.F.  , and   J.D.     Robishaw  .   2001  .   Heterotrimeric G-protein 
betagamma-dimers in growth and diff  erentiation.       Oncogene      .     20  :  1653  –
  1660  .   doi:10.1038/sj.onc.1204181     
      Shajahan  ,   A.N.  ,   C.     Tiruppathi  ,   A.V.     Smrcka  ,   A.B.     Malik  , and   R.D.   
  Minshall  .   2004  .   Gbetagamma activation of Src induces caveolae-
mediated endocytosis in endothelial cells.       J. Biol. Chem.       279  :  48055  –
  48062  .   doi:10.1074/jbc.M405837200     
      Singh  ,   I.  ,   N.     Knezevic  ,   G.U.     Ahmmed  ,   V.     Kini  ,   A.B.     Malik  , and   D.     Mehta  . 
  2007  .   Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation 
and resultant endothelial cell shape change in response to thrombin.   
    J. Biol. Chem.       282  :  7833  –  7843  .   doi:10.1074/jbc.M608288200     
      Suzuki  ,   H.  ,   E.D.     Motley  ,   K.     Eguchi  ,   A.     Hinoki  ,   H.     Shirai  ,   V.     Watts  ,   L.N.   
  Stemmle  ,   T.A.     Fields  , and   S.     Eguchi  .   2009  .   Distinct roles of prote-
ase-activated receptors in signal transduction regulation of endothe-
lial nitric oxide synthase.       Hypertension      .     53  :  182  –  188  .   doi:10.1161/
HYPERTENSIONAHA.108.125229     
      Swift  ,   S.  ,   P.J.     Sheridan  ,   L.     Covic  , and   A.     Kuliopulos  .   2000  .   PAR1 thrombin 
receptor-G protein interactions. Separation of binding and coupling deter-
minants in the galpha subunit.     J. Biol. Chem.      275  :  2627  –  2635  .  doi:10.1074/
jbc.275.4.2627     
      Tang  ,   W.J.  , and   A.G.     Gilman  .   1992  .   Adenylyl cyclases.       Cell      .     70  :  869  –  872  . 
  doi:10.1016/0092-8674(92)90236-6     
      Taurin  ,   S.  ,   K.     Hogarth  ,   N.     Sandbo  ,   D.M.     Yau  , and   N.O.     Dulin  .   2007  . 
  Gbetagamma-mediated prostacyclin production and cAMP-dependent 
protein kinase activation by endothelin-1 promotes vascular smooth 
muscle cell hypertrophy through inhibition of glycogen synthase kinase-
3.       J. Biol. Chem.       282  :  19518  –  19525  .   doi:10.1074/jbc.M702655200     
      Tauseef  ,   M.  ,   V.     Kini  ,   N.     Knezevic  ,   M.     Brannan  ,   R.     Ramchandaran  ,   H.   
  Fyrst  ,   J.     Saba  ,   S.M.     Vogel  ,   A.B.     Malik  , and   D.     Mehta  .   2008  .   Activation 
receptors 1 and 4 mediate thrombin signaling in endothelial cells.       Blood      .   
  102  :  3224  –  3231  .   doi:10.1182/blood-2003-04-1130     
      Knezevic  ,   N.  ,   A.     Roy  ,   B.     Timblin  ,   M.     Konstantoulaki  ,   T.     Sharma  ,   A.B.   
  Malik  , and   D.     Mehta  .   2007  .   GDI-1 phosphorylation switch at serine 96 
induces RhoA activation and increased endothelial permeability.       Mol. 
Cell. Biol.       27  :  6323  –  6333  .   doi:10.1128/MCB.00523-07     
      Korhonen  ,   H.  ,   B.     Fisslthaler  ,   A.     Moers  ,   A.     Wirth  ,   D.     Habermehl  ,   T.   
  Wieland  ,   G.     Schütz  ,   N.     Wettschureck  ,   I.     Fleming  , and   S.     Off  ermanns  . 
  2009  .   Anaphylactic shock depends on endothelial Gq/G11.       J. Exp. 
Med.       206  :  411  –  420  .   doi:10.1084/jem.20082150     
      Kouklis  ,   P.  ,   M.     Konstantoulaki  ,   S.     Vogel  ,   M.     Broman  , and   A.B.     Malik  . 
  2004  .   Cdc42 regulates the restoration of endothelial barrier function.   
    Circ. Res.       94  :  159  –  166  .   doi:10.1161/01.RES.0000110418.38500.31     
      Landis  ,   R.C.     2007  .   Protease activated receptors: clinical relevance to hemo-
stasis and infl  ammation.       Hematol. Oncol. Clin. North Am.       21  :  103  –  113  . 
  doi:10.1016/j.hoc.2006.11.005     
      Li  ,   X.  ,   M.     Stankovic  ,   C.S.     Bonder  ,   C.N.     Hahn  ,   M.     Parsons  ,   S.M.     Pitson  ,   P.   
  Xia  ,   R.L.     Proia  ,   M.A.     Vadas  , and   J.R.     Gamble  .   2008  .   Basal and angio-
poietin-1-mediated endothelial permeability is regulated by sphingosine 
kinase-1.       Blood      .     111  :  3489  –  3497  .   doi:10.1182/blood-2007-05-092148     
      Liu  ,   K.D.  , and   M.A.     Matthay  .   2008  .   Advances in critical care for the ne-
phrologist: acute lung injury/ARDS.       Clin. J. Am. Soc. Nephrol.       3  :  578  –
  586  .   doi:10.2215/CJN.01630407     
      Luttrell  ,   L.M.  ,   B.E.     Hawes  ,   T.     van Biesen  ,   D.K.     Luttrell  ,   T.J.     Lansing  , 
and   R.J.     Lefkowitz  .   1996  .   Role of c-Src tyrosine kinase in G protein-
coupled receptor- and Gbetagamma subunit-mediated activation of 
mitogen-activated protein kinases.       J. Biol. Chem.       271  :  19443  –  19450  .    
      McGarrigle  ,   D.  , and   X.Y.     Huang  .   2007  .   GPCRs signaling directly through 
Src-family kinases.       Sci. STKE      .     392  :  pe35  .   
      McLaughlin  ,   J.N.  ,   L.     Shen  ,   M.     Holinstat  ,   J.D.     Brooks  ,   E.     Dibenedetto  , and 
  H.E.     Hamm  .   2005  .   Functional selectivity of G protein signaling by ago-
nist peptides and thrombin for the protease-activated receptor-1.       J. Biol. 
Chem.       280  :  25048  –  25059  .   doi:10.1074/jbc.M414090200     
      McLaughlin  ,   J.N.  ,   M.M.     Patterson  , and   A.B.     Malik  .   2007  .   Protease-activated 
receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.     Proc. 
Natl. Acad. Sci. USA      .     104  :  5662  –  5667  .   doi:10.1073/pnas.0700763104     
      Mehta  ,   D.  , and   A.B.     Malik  .   2006  .   Signaling mechanisms regulating endothelial 
permeability.       Physiol. Rev.       86  :  279  –  367  .   doi:10.1152/physrev.00012.2005     
      Mehta  ,   D.  ,   A.     Rahman  , and   A.B.     Malik  .   2001  .   Protein kinase C-alpha sig-
nals rho-guanine nucleotide dissociation inhibitor phosphorylation and 
rho activation and regulates the endothelial cell barrier function.       J. Biol. 
Chem.       276  :  22614  –  22620  .   doi:10.1074/jbc.M101927200     
      Mehta  ,   D.  ,   C.     Tiruppathi  ,   R.     Sandoval  ,   R.D.     Minshall  ,   M.     Holinstat  , and 
  A.B.     Malik  .   2002  .   Modulatory role of focal adhesion kinase in regulat-
ing human pulmonary arterial endothelial barrier function.       J. Physiol.     
  539  :  779  –  789  .   doi:10.1113/jphysiol.2001.013289     
      Mitra  ,  S.K.  , and  D.D.    Schlaepfer  .  2006  .  Integrin-regulated FAK-Src signaling 
in normal and cancer cells.     Curr. Opin. Cell Biol.      18  :  516  –  523  .  doi:10.1016/
j.ceb.2006.08.011     
      Mourton  ,   T.  ,   C.B.     Hellberg  ,   S.M.     Burden-Gulley  ,   J.     Hinman  ,   A.     Rhee  , and 
  S.M.     Brady-Kalnay  .   2001  .   The PTPmu protein-tyrosine phosphatase 
binds and recruits the scaff  olding protein RACK1 to cell-cell contacts.   
    J. Biol. Chem.       276  :  14896  –  14901  .   doi:10.1074/jbc.M010823200     
      Neer  ,   E.J.  ,   C.J.     Schmidt  ,   R.     Nambudripad  , and   T.F.     Smith  .   1994  .   The 
ancient regulatory-protein family of WD-repeat proteins.       Nature      .   
  371  :  297  –  300  .   doi:10.1038/371297a0     
      Nelson  ,  C.M.  ,  D.M.    Pirone  ,  J.L.    Tan  , and  C.S.    Chen  .  2004  .  Vascular endothelial-
cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions 
by stimulating RhoA.       Mol. Biol. Cell      .     15  :  2943  –  2953  .   doi:10.1091/mbc
.E03-10-0745     
      Neptune  ,   E.R.  , and   H.R.     Bourne  .   1997  .   Receptors induce chemotaxis by 
releasing the betagamma subunit of Gi, not by activating Gq or Gs.       Proc. 
Natl. Acad. Sci. USA      .     94  :  14489  –  14494  .   doi:10.1073/pnas.94.26.14489     
      Nishio  ,   M.  ,   K.     Watanabe  ,   J.     Sasaki  ,   C.     Taya  ,   S.     Takasuga  ,   R.     Iizuka  ,   T.   
  Balla  ,   M.     Yamazaki  ,   H.     Watanabe  ,   R.     Itoh  ,   et al  .   2007  .   Control of cell 
polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.       Nat. 
Cell Biol.       9  :  36  –  44  .   doi:10.1038/ncb1515     
      Niu  ,   J.  ,   J.     Profi  rovic  ,   H.     Pan  ,   R.     Vaiskunaite  , and   T.     Voyno-Yasenetskaya  . 
  2003  .  G Protein betagamma subunits stimulate p114RhoGEF, a guanine nu-JEM VOL. 206, November 23, 2009 
Article
2777
of sphingosine kinase-1 reverses the increase in lung vascular permeability 
through sphingosine-1-phosphate receptor signaling in endothelial cells.   
    Circ. Res.       103  :  1164  –  1172  .   doi:10.1161/01.RES.0000338501.84810.51     
      Thomas  ,   S.M.  , and   J.S.     Brugge  .   1997  .   Cellular functions regulated by Src 
family kinases.       Annu. Rev. Cell Dev. Biol.       13  :  513  –  609  .   doi:10.1146/
annurev.cellbio.13.1.513     
      Thompson  ,   M.D.  ,   D.E.     Cole  , and   P.A.     Jose  .   2008  .   Pharmacogenomics of 
G protein-coupled receptor signaling: insights from health and disease.   
    Methods Mol. Biol.       448  :  77  –  107  .   doi:10.1007/978-1-59745-205-2_6     
      Thornton  ,  C.  ,  K.C.    Tang  ,  K.    Phamluong  ,  K.    Luong  ,  A.    Vagts  ,  D.    Nikanjam  ,  R.   
  Yaka  , and  D.    Ron  .  2004  .  Spatial and temporal regulation of RACK1 func-
tion and N-methyl-D-aspartate receptor activity through WD40 motif-
mediated dimerization.       J. Biol. Chem.       279  :  31357  –  31364  .   doi:10.1074/
jbc.M402316200     
      Tiruppathi  ,  C.  ,  R.D.    Minshall  ,  B.C.    Paria  ,  S.M.    Vogel  , and  A.B.    Malik  .  2002  . 
  Role of Ca2+ signaling in the regulation of endothelial permeability.   
    Vascul. Pharmacol.       39  :  173  –  185  .   doi:10.1016/S1537-1891(03)00007-7     
      van Buul  ,   J.D.  ,   E.C.     Anthony  ,   M.     Fernandez-Borja  ,   K.     Burridge  , and   P.L.   
  Hordijk  .   2005  .   Proline-rich tyrosine kinase 2 (Pyk2) mediates vascu-
lar endothelial-cadherin-based cell-cell adhesion by regulating beta-
catenin tyrosine phosphorylation.       J. Biol. Chem.       280  :  21129  –  21136  . 
  doi:10.1074/jbc.M500898200     
      Vogel  ,   S.M.  ,   X.     Gao  ,   D.     Mehta  ,   R.D.     Ye  ,   T.A.     John  ,   P.     Andrade-Gordon  , 
  C.     Tiruppathi  , and   A.B.     Malik  .   2000  .   Abrogation of thrombin-induced 
increase in pulmonary microvascular permeability in PAR-1 knockout 
mice.       Physiol. Genomics      .     4  :  137  –  145  .   
      Wu  ,   M.H.     2005  .   Endothelial focal adhesions and barrier function.       J. Physiol.     
  569  :  359  –  366  .   doi:10.1113/jphysiol.2005.096537     
      Xing  ,   Z.  ,   H.C.     Chen  ,   J.K.     Nowlen  ,   S.J.     Taylor  ,   D.     Shalloway  , and   J.L.   
  Guan  .   1994  .   Direct interaction of v-Src with the focal adhesion kinase 
mediated by the Src SH2 domain.       Mol. Biol. Cell      .     5  :  413  –  421  .   
      Yaka  ,   R.  ,   C.     Thornton  ,   A.J.     Vagts  ,   K.     Phamluong  ,   A.     Bonci  , and   D.     Ron  . 
  2002  .   NMDA receptor function is regulated by the inhibitory scaf-
folding protein, RACK1.       Proc. Natl. Acad. Sci. USA      .     99  :  5710  –  5715  . 
  doi:10.1073/pnas.062046299     
      Yuan  ,   S.Y.     2002  .   Protein kinase signaling in the modulation of microvascular 
permeability.       Vascul. Pharmacol.       39  :  213  –  223  .   doi:10.1016/S1537-1891
(03)00010-7                             